IDH2 and astrocytoma (excluding glioblastoma): Further, whether patients diagnosed with IDH-mutant astrocytoma, CNS WHO grade 4, should be treated like IDH-wildtype glioblastoma patients or rather like patients with IDH-mutant astrocytoma, CNS WHO grade 3, remains controversial [47].